Skip to main content

Advertisement

SpringerLink
Log in

Endoscopic Anti-Reflux Procedures: Ready for Clinical Use?

  • Endoscopy (P Siersema, Section Editor)
  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Abstract

Purpose of review

Endoscopic intervention is one of the therapeutic modalities that are currently available for GERD. Endoscopic treatment for GERD has been recently positioned as an alternative for chronic medical therapy or anti-reflux surgery. Patients who are candidates for these procedures include those with typical symptoms of GERD, low-grade erosive esophagitis (Los Angeles A and B), abnormal esophageal acid exposure if normal endoscopy, small hiatal hernia (< 3 cm), and partial or complete response to PPI treatment. This review will highlight the present and emerging data available about current and new endoscopic therapeutic modalities for GERD.

Recent findings

Presently, there are three endoscopic techniques that are approved for GERD, including the Stretta procedure, transoral incisionless fundoplication (TIF), and Medigus ultrasonic surgical endostapler (MUSE). Overall, all endoscopic techniques for GERD have reported excellent control of GERD-related symptoms, improvement of health-related quality of life, durability, and safety. However, the quality of evidence to support these claims varies greatly from one procedure to the other. Furthermore, there is an important discrepancy between improvement of subjective clinical parameters versus objective clinical parameters. There is a growing interest in positioning the endoscopic techniques in patient’s post-bariatric surgery, after peroral endoscopic myotomy (POEM), and in those who also require hiatal hernia repair. There are several new endoscopic interventions for GERD that are currently under investigation.

Summary

Endoscopic techniques are currently part of our therapeutic armamentarium for GERD. Criticism about their limited effect on objective clinical endpoints has tempered the enthusiasm of patients and physicians alike about their therapeutic value. However, endoscopic therapy for GERD is here to stay as more patients are looking for alternatives to medical and surgical therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References and Recommended Reading

  1. El-Serag HB, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63(6):871–80.

    Article  PubMed  Google Scholar 

  2. Sandhu DS, Fass R. Current trends in the management of gastroesophageal reflux disease. Gut Liver. 2018;12(1):7–16.

    Article  CAS  PubMed  Google Scholar 

  3. Shaheen NJ, et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol. 2006;101(9):2128–38.

    Article  PubMed  Google Scholar 

  4. Lagergren J, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340(11):825–31.

    Article  CAS  PubMed  Google Scholar 

  5. Ness-Jensen E, et al. Lifestyle intervention in gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2016;14(2):175–82 e1–3.

    Article  PubMed  Google Scholar 

  6. Banerjee S, et al. Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention. Am J Cardiol. 2011;107(6):871–8.

    Article  CAS  PubMed  Google Scholar 

  7. Girgis CM, Sher D, Seibel MJ. Atypical femoral fractures and bisphosphonate use. N Engl J Med. 2010;362(19):1848–9.

    Article  CAS  PubMed  Google Scholar 

  8. Heidelbaugh JJ, Goldberg KL, Inadomi JM. Adverse risks associated with proton pump inhibitors: a systematic review. Gastroenterol Hepatol. 2009;5(10):725–34.

    Google Scholar 

  9. Kellokumpu I, et al. Quality of life following laparoscopic Nissen fundoplication: assessing short-term and long-term outcomes. World J Gastroenterol. 2013;19(24):3810–8.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Grant A, et al. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease—a UK collaborative study. The Reflux Trial Health Technol Assess. 2008;12(31):1–181 iii-iv.

  11. Galmiche JP, et al. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA. 2011;305(19):1969–77.

    Article  CAS  PubMed  Google Scholar 

  12. Shibli F, Kitayama Y, Fass R. Novel therapies for gastroesophageal reflux disease: beyond proton pump inhibitors. Curr Gastroenterol Rep. 2020;22(4):16.

    Article  PubMed  Google Scholar 

  13. Nabi Z, Reddy DN. Endoscopic management of gastroesophageal reflux disease: revisited. Clin Endosc. 2016;49(5):408–16.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Fass R. Endoscopic approaches for the treatment of gastroesophageal reflux disease. Gastroenterol Hepatol. 2019;15(10):555–7.

    Google Scholar 

  15. Sandhu DS and Fass R, Stretta therapy in the management of gastroesophageal reflux disease (GERD). Ann Esophagus, 2019. 2.

  16. Sowa P, Samarasena JB. Nonablative radiofrequency treatment for gastroesophageal reflux disease (STRETTA). Gastrointest Endosc Clin N Am. 2020;30(2):253–65.

    Article  PubMed  Google Scholar 

  17. Jackman WM, et al. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med. 1991;324(23):1605–11.

    Article  CAS  PubMed  Google Scholar 

  18. Utley DS, et al. Augmentation of lower esophageal sphincter pressure and gastric yield pressure after radiofrequency energy delivery to the gastroesophageal junction: a porcine model. Gastrointest Endosc. 2000;52(1):81–6.

    Article  CAS  PubMed  Google Scholar 

  19. Chang K and Utley D. Endoscopic ultrasound (EUS) in-vivo assessment of radiofrequency (RF) energy delivery to the gastroesophageal (GE) junction in a porcine model. in GASTROINTESTINAL ENDOSCOPY. 2001. MOSBY, INC 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146–3318 USA.

  20. Lidums I, et al. Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. Gastroenterology. 2000;118(1):7–13.

    Article  CAS  PubMed  Google Scholar 

  21. Auyang ED, et al. SAGES clinical spotlight review: endoluminal treatments for gastroesophageal reflux disease (GERD). Surg Endosc. 2013;27(8):2658–72.

    Article  PubMed  Google Scholar 

  22. Vaezi MF, Shaheen NJ, Muthusamy VR. State of evidence in minimally invasive management of gastroesophageal reflux: findings of a scoping review. Gastroenterology. 2020.

  23. Triadafilopoulos G, et al. The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc. 2002;55(2):149–56.

    Article  PubMed  Google Scholar 

  24. Corley DA, et al. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology. 2003;125(3):668–76.

    Article  PubMed  Google Scholar 

  25. Aziz AM, et al. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease. Surg Endosc. 2010;24(4):818–25.

    Article  PubMed  Google Scholar 

  26. Coron E, et al. Clinical trial: radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients. Aliment Pharmacol Ther. 2008;28(9):1147–58.

    Article  CAS  PubMed  Google Scholar 

  27. Arts J, et al. A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD. Am J Gastroenterol. 2012;107(2):222–30.

    Article  CAS  PubMed  Google Scholar 

  28. Perry KA, Banerjee A, Melvin WS. Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: a systematic review and meta-analysis. Surg Laparosc Endosc Percutan Tech. 2012;22(4):283–8.

    Article  PubMed  Google Scholar 

  29. Lipka S, Kumar A, Richter JE. No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2015;13(6):1058–67 e1.

    Article  PubMed  Google Scholar 

  30. Fass R, et al. Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease. Surg Endosc. 2017;31(12):4865–82.

    Article  PubMed  Google Scholar 

  31. Zerbib F, et al. Randomised clinical trial: oesophageal radiofrequency energy delivery versus sham for PPI-refractory heartburn. Aliment Pharmacol Ther. 2020;52(4):637–45.

    Article  PubMed  Google Scholar 

  32. He S, et al. Stretta procedure versus proton pump inhibitors for the treatment of nonerosive reflux disease: a 6-month follow-up. Medicine (Baltimore). 2020;99(3):e18610.

    Article  CAS  Google Scholar 

  33. Noar M, Squires P, Khan S. Radiofrequency energy delivery to the lower esophageal sphincter improves gastroesophageal reflux patient-reported outcomes in failed laparoscopic Nissen fundoplication cohort. Surg Endosc. 2017;31(7):2854–62.

    Article  PubMed  Google Scholar 

  34. Guerron D, Portenier D. A case series on gastroesophageal reflux disease and the bariatric patients: Stretta therapy as a non-surgical option. Bariatric Times. 2016;13(11):18–20.

    Google Scholar 

  35. Khidir N, et al. Initial Experience of endoscopic radiofrequency waves delivery to the lower esophageal sphincter (Stretta procedure) on symptomatic gastroesophageal reflux disease post-sleeve gastrectomy. Obes Surg. 2018;28(10):3125–30.

    Article  PubMed  Google Scholar 

  36. Mattar SG, et al. Treatment of refractory gastroesophageal reflux disease with radiofrequency energy (Stretta) in patients after Roux-en-Y gastric bypass. Surg Endosc. 2006;20(6):850–4.

    Article  CAS  PubMed  Google Scholar 

  37. Fass R. An overview of transoral incisionless fundoplication and magnetic sphincter augmentation for GERD. Gastroenterol Hepatol (N Y). 2017;13(1):50–2.

    Google Scholar 

  38. Ihde GM. The evolution of TIF: transoral incisionless fundoplication. Ther Adv Gastroenterol. 2020;13:1756284820924206.

    Article  Google Scholar 

  39. Chang KJ, Bell R. Transoral incisionless fundoplication. Gastrointest Endosc Clin. 2020;30(2):267–89.

    Article  Google Scholar 

  40. Horgan S, Pellegrini CA. Surgical treatment of gastroesophageal reflux disease. Surg Clin North Am. 1997;77(5):1063–82.

    Article  CAS  PubMed  Google Scholar 

  41. Ihde GM, Besancon K, Deljkich E. Short-term safety and symptomatic outcomes of transoral incisionless fundoplication with or without hiatal hernia repair in patients with chronic gastroesophageal reflux disease. Am J Surg. 2011;202(6):740–6 discussion 746–7.

    Article  PubMed  Google Scholar 

  42. Rinsma NF, et al. Effect of transoral incisionless fundoplication on reflux mechanisms. Surg Endosc. 2014;28(3):941–9.

    Article  PubMed  Google Scholar 

  43. Sami Trad K. Transoral incisionless fundoplication: current status. Curr Opin Gastroenterol. 2016;32(4):338–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Cadière GB, et al. Endoluminal fundoplication by a transoral device for the treatment of GERD: a feasibility study. Surg Endosc. 2008;22(2):333–42.

    Article  PubMed  Google Scholar 

  45. Cadière GB, et al. Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. World J Surg. 2008;32(8):1676–88.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Cadière GB, et al. Two-year results of a feasibility study on antireflux transoral incisionless fundoplication using EsophyX. Surg Endosc. 2009;23(5):957–64.

    Article  PubMed  Google Scholar 

  47. Witteman BP, et al. Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice. Surg Endosc. 2012;26(11):3307–15.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Huang X, et al. Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis. Surg Endosc. 2017;31(3):1032–44.

    Article  PubMed  Google Scholar 

  49. Jain D, Singhal S. Transoral incisionless fundoplication for refractory gastroesophageal reflux disease: where do we stand? Clin Endosc. 2016;49(2):147–56.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Testoni PA, Mazzoleni G, Testoni SG. Transoral incisionless fundoplication for gastro-esophageal reflux disease: techniques and outcomes. World J Gastrointest Pharmacol Ther. 2016;7(2):179–89.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Hunter JG, et al. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology. 2015;148(2):324–33 e5.

    Article  CAS  PubMed  Google Scholar 

  52. Witteman BP, et al. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2015;110(4):531–42.

    Article  CAS  PubMed  Google Scholar 

  53. Håkansson B, et al. Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD. Aliment Pharmacol Ther. 2015;42(11–12):1261–70.

    Article  PubMed  Google Scholar 

  54. Testoni PA, et al. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study. Surg Endosc. 2015;29(9):2770–80.

    Article  PubMed  Google Scholar 

  55. Stefanidis G, et al. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy. Dis Esophagus. 2017;30(3):1–8.

    PubMed  Google Scholar 

  56. Richter JE, et al. Efficacy of laparoscopic Nissen fundoplication vs transoral incisionless fundoplication or proton pump inhibitors in patients with gastroesophageal reflux disease: a systematic review and network meta-analysis. Gastroenterology. 2018;154(5):1298–308 e7.

  57. Trad KS, et al. Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm. Surg Endosc. 2017;31(6):2498–508.

    Article  PubMed  Google Scholar 

  58. Trad KS, et al. The TEMPO Trial at 5 years: transoral fundoplication (TIF 2.0) is safe, durable, and cost-effective. Surg Innov. 2018;25(2):149–57.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Kahrilas PJ, et al. Transoral esophagogastric fundoplication provides quality-of-life improvement and sustained symptom and esophageal ph control: a randomized, sham-controlled, crossover trial: 1666. Am J Gastroenterol. 2015;110:S710.

    Article  Google Scholar 

  60. Testoni PA, et al. Transoral incisionless fundoplication with EsophyX for gastroesophageal reflux disease: clinical efficacy is maintained up to 10 years. Endosc Int Open. 2019;7(5):E647–54.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Ihde GM 2nd, et al. pH Scores in Hiatal Repair with Transoral Incisionless Fundoplication. JSLS. 2019;23(1):e2018.00087.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Janu P, et al. Laparoscopic hiatal hernia repair followed by transoral incisionless fundoplication with EsophyX device (HH + TIF): efficacy and safety in two community hospitals. Surg Innov. 2019;26(6):675–86.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Gisi C, et al. Efficacy and patient satisfaction of single-session transoral incisionless fundoplication and laparoscopic hernia repair. Surg Endosc. 2020;35(2):921–7.

    Article  PubMed  Google Scholar 

  64. Repici A, et al. GERD after per-oral endoscopic myotomy as compared with Heller’s myotomy with fundoplication: a systematic review with meta-analysis. Gastrointest Endosc. 2018;87(4):934–43 e18.

    Article  PubMed  Google Scholar 

  65. Marano L, et al. Surgery or peroral esophageal myotomy for achalasia: a systematic review and meta-analysis. Medicine (Baltimore). 2016;95(10):e3001.

    Article  Google Scholar 

  66. Schlottmann F, et al. Laparoscopic Heller myotomy versus Peroral Endoscopic Myotomy (POEM) for Achalasia: a systematic review and meta-analysis. Ann Surg. 2018;267(3):451–60.

    Article  PubMed  Google Scholar 

  67. Brewer Gutierrez OI, Benias PC, Khashab MA. Same-session per-oral endoscopic myotomy followed by transoral incisionless fundoplication in achalasia: are we there yet? Am J Gastroenterol. 2020;115(2):162.

    Article  PubMed  Google Scholar 

  68. Haito Chavez Y, et al. Transoral incisionless endoscopic fundoplication guided by impedance planimetry to treat severe GERD symptoms after per-oral endoscopic myotomy. Gastrointest Endosc. 2017;85(1):254–5.

    Article  PubMed  Google Scholar 

  69. Kumta NA, et al. Transoral incisionless fundoplication for treatment of refractory GERD after peroral endoscopic myotomy. Gastrointest Endosc. 2015;81(1):224–5.

    Article  PubMed  Google Scholar 

  70. Tyberg A, et al. Transoral incisional fundoplication for reflux after peroral endoscopic myotomy: a crucial addition to our arsenal. Endosc Int Open. 2018;6(5):E549–52.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Zacherl J, et al. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial. Surg Endosc. 2015;29(1):220–9.

    Article  PubMed  Google Scholar 

  72. Thosani N, et al. Endoscopic anti-reflux devices (with videos). Gastrointest Endosc. 2017;86(6):931–48.

    Article  PubMed  Google Scholar 

  73. Kim HJ, et al. Long-term follow-up results of endoscopic treatment of gastroesophageal reflux disease with the MUSE™ endoscopic stapling device. Surg Endosc. 2016;30(8):3402–8.

    Article  PubMed  Google Scholar 

  74. Roy-Shapira A, et al. Trans-oral anterior fundoplication: 5-year follow-up of pilot study. Surg Endosc. 2015;29(12):3717–21.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Nabi Z, Reddy DN. Update on endoscopic approaches for the management of gastroesophageal reflux disease. Gastroenterol Hepatol (N Y). 2019;15(7):369–76.

    Google Scholar 

  76. Weitzendorfer M, et al. Clinical feasibility of a new full-thickness endoscopic plication device (GERDx™) for patients with GERD: results of a prospective trial. Surg Endosc. 2018;32(5):2541–9.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Weitzendorfer M, et al. Interim report of a prospective trial on the clinical efficiency of a new full-thickness endoscopic plication device for patients with GERD: impact of changed suture material. Surg Laparosc Endosc Percutan Tech. 2017;27(3):163–9.

    Article  PubMed  Google Scholar 

  78. Hedberg HM, Kuchta K, Ujiki MB. First experience with banded anti-reflux mucosectomy (ARMS) for GERD: feasibility, safety, and technique (with video). J Gastrointest Surg. 2019;23(6):1274–8.

    Article  PubMed  Google Scholar 

  79. Inoue H, et al. Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study. Ann Gastroenterol. 2014;27(4):346–51.

    PubMed  PubMed Central  Google Scholar 

  80. Benias PC, et al. Initial experience with a novel resection and plication (RAP) method for acid reflux: a pilot study. Endosc Int Open. 2018;6(4):E443–9.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Yoo IK, et al. Anti-reflux mucosectomy using a cap-assisted endoscopic mucosal resection method for refractory gastroesophageal disease: a prospective feasibility study. Surg Endosc. 2020;34(3):1124–31.

    Article  PubMed  Google Scholar 

  82. Seleem WM, Hanafy AS, Mohamed SI. Endoscopic management of refractory gastroesophageal reflux disease. Scand J Gastroenterol. 2018;53(4):390–7.

    Article  PubMed  Google Scholar 

  83. Hu HQ, et al. Peroral endoscopic cardial constriction in gastroesophageal reflux disease. Medicine (Baltimore). 2018;97(15):e0169.

    Article  Google Scholar 

  84. Inoue H, et al. Anti-reflux mucosal ablation (ARMA) as a new treatment for gastroesophageal reflux refractory to proton pump inhibitors: a pilot study. Endosc Int Open. 2020;8(2):E133–8.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Tanabe M, et al. 878 Clinical outcomes of endoscopic anti-reflux treatment methods; Anti-Reflux Mucosectomy (ARMS) and Anti-Reflux Mucosal Ablation (ARMA). Gastrointest Endosc. 2020;91(6):AB72.

    Article  Google Scholar 

  86. Hernández Mondragón OV, et al. Clinical feasibility of a new antireflux ablation therapy on gastroesophageal reflux disease (with video). Gastrointest Endosc. 2020;92(6):1190–201.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Esophageal and Swallowing Center, Division of Gastroenterology and Hepatology, Digestive Health Center, MetroHealth Medical System, Case Western Reserve University, 2500 MetroHealth Drive, Cleveland, OH, 44109, USA

    Fahmi Shibli MD & Ronnie Fass MD, FACG

Authors
  1. Fahmi Shibli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ronnie Fass MD, FACG
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ronnie Fass MD, FACG.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Human and animal rights and informed consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Endoscopy

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shibli, F., Fass, R. Endoscopic Anti-Reflux Procedures: Ready for Clinical Use?. Curr Treat Options Gastro 19, 399–420 (2021). https://doi.org/10.1007/s11938-021-00351-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-021-00351-0

Keywords

Search

Navigation